Effect of CRY2 stabilizer and proteasome inhibitor on the transcription of MDA-MB-231 cells [RNA-seq]
RNA-seq (gene expression) · human · 36 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 36 samples: 12 conditions, mostly in triplicateGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Targeting circadian transcriptional programs through a cis-regulatory mechanism in triple negative breast cancerbioRxiv : the preprint server for biology · 2024
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE266011_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1105320 and SRA study SRP504374. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 36 samples.
How we read this: 12 replicated groups read from 36 sample titles; they account for 36 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8239391 MDA-MB-231, MG_combination_DMSO-treated, 8-hour treatment, rep1 MDA-MB-231, MG_combinat…
- GSM8239392 MDA-MB-231, MG_combination_DMSO-treated, 8-hour treatment, rep2 MDA-MB-231, MG_combinat…
- GSM8239393 MDA-MB-231, MG_combination_DMSO-treated, 8-hour treatment, rep3 MDA-MB-231, MG_combinat…
- GSM8239394 MDA-MB-231, MG_combination_SHP1705-treated, 8-hour treatment, rep1 MDA-MB-231, MG_combinat…
- GSM8239395 MDA-MB-231, MG_combination_SHP1705-treated, 8-hour treatment, rep2 MDA-MB-231, MG_combinat…
- GSM8239396 MDA-MB-231, MG_combination_SHP1705-treated, 8-hour treatment, rep3 MDA-MB-231, MG_combinat…
- GSM8239397 MDA-MB-231, MG_combination_MG132-treated, 8-hour treatment, rep1 MDA-MB-231, MG_combinat…
- GSM8239398 MDA-MB-231, MG_combination_MG132-treated, 8-hour treatment, rep2 MDA-MB-231, MG_combinat…
- GSM8239399 MDA-MB-231, MG_combination_MG132-treated, 8-hour treatment, rep3 MDA-MB-231, MG_combinat…
- GSM8239400 MDA-MB-231, MG_combination_drug combination-treated, 8-hour treatment, rep1 MDA-MB-231, MG_combinat…
- GSM8239401 MDA-MB-231, MG_combination_drug combination-treated, 8-hour treatment, rep2 MDA-MB-231, MG_combinat…
- GSM8239402 MDA-MB-231, MG_combination_drug combination-treated, 8-hour treatment, rep3 MDA-MB-231, MG_combinat…
- GSM8239403 MDA-MB-231, CFZ_combination_DMSO-treated, 8-hour treatment, rep1 MDA-MB-231, CFZ_combina…
- GSM8239404 MDA-MB-231, CFZ_combination_DMSO-treated, 8-hour treatment, rep2 MDA-MB-231, CFZ_combina…
- GSM8239405 MDA-MB-231, CFZ_combination_DMSO-treated, 8-hour treatment, rep3 MDA-MB-231, CFZ_combina…
- GSM8239406 MDA-MB-231, CFZ_combination_SHP1705-treated, 8-hour treatment, rep1 MDA-MB-231, CFZ_combina…
- GSM8239407 MDA-MB-231, CFZ_combination_SHP1705-treated, 8-hour treatment, rep2 MDA-MB-231, CFZ_combina…
- GSM8239408 MDA-MB-231, CFZ_combination_SHP1705-treated, 8-hour treatment, rep3 MDA-MB-231, CFZ_combina…
- GSM8239409 MDA-MB-231, CFZ_combination_CFZ-treated, 8-hour treatment, rep1 MDA-MB-231, CFZ_combina…
- GSM8239410 MDA-MB-231, CFZ_combination_CFZ-treated, 8-hour treatment, rep2 MDA-MB-231, CFZ_combina…
- GSM8239411 MDA-MB-231, CFZ_combination_CFZ-treated, 8-hour treatment, rep3 MDA-MB-231, CFZ_combina…
- GSM8239412 MDA-MB-231, CFZ_combination_drug combination-treated, 8-hour treatment, rep1 MDA-MB-231, CFZ_combina…
- GSM8239413 MDA-MB-231, CFZ_combination_drug combination-treated, 8-hour treatment, rep2 MDA-MB-231, CFZ_combina…
- GSM8239414 MDA-MB-231, CFZ_combination_drug combination-treated, 8-hour treatment, rep3 MDA-MB-231, CFZ_combina…
- GSM8239415 MDA-MB-231, CFZ_combination_DMSO-treated, 24-hour treatment, rep1 MDA-MB-231, CFZ_combina…
- GSM8239416 MDA-MB-231, CFZ_combination_DMSO-treated, 24-hour treatment, rep2 MDA-MB-231, CFZ_combina…
- GSM8239417 MDA-MB-231, CFZ_combination_DMSO-treated, 24-hour treatment, rep3 MDA-MB-231, CFZ_combina…
- GSM8239418 MDA-MB-231, CFZ_combination_SHP1705-treated, 24-hour treatment, rep1 MDA-MB-231, CFZ_combina…
- GSM8239419 MDA-MB-231, CFZ_combination_SHP1705-treated, 24-hour treatment, rep2 MDA-MB-231, CFZ_combina…
- GSM8239420 MDA-MB-231, CFZ_combination_SHP1705-treated, 24-hour treatment, rep3 MDA-MB-231, CFZ_combina…
- GSM8239421 MDA-MB-231, CFZ_combination_CFZ-treated, 24-hour treatment, rep1 MDA-MB-231, CFZ_combina…
- GSM8239422 MDA-MB-231, CFZ_combination_CFZ-treated, 24-hour treatment, rep2 MDA-MB-231, CFZ_combina…
- GSM8239423 MDA-MB-231, CFZ_combination_CFZ-treated, 24-hour treatment, rep3 MDA-MB-231, CFZ_combina…
- GSM8239424 MDA-MB-231, CFZ_combination_drug combination-treated, 24-hour treatment, rep1 MDA-MB-231, CFZ_combina…
- GSM8239425 MDA-MB-231, CFZ_combination_drug combination-treated, 24-hour treatment, rep2 MDA-MB-231, CFZ_combina…
- GSM8239426 MDA-MB-231, CFZ_combination_drug combination-treated, 24-hour treatment, rep3 MDA-MB-231, CFZ_combina…
- GSE297242 Effect of lactate accumulation on translation and transcription in MDA-MB-231 breast cancer cells 12 samples shares mda-mb-231, transcription
- GSE269826 Conserved patterns of transcriptional dysregulation, heterogeneity and cell states in clear cell kidney cancer [scRNA-seq] 79 samples shares transcription, rna-seq
- GSE189357 Spatiotemporal transcriptional atlas of lung adenocarcinoma from adenocarcinoma in situ to invasive carcinoma [scRNA-seq] 9 samples shares transcription, rna-seq
- GSE318861 Quantitative analysis of Tat-dependent and host-driven HIV transcription by ChIP-seq and RNA-seq 52 samples shares transcription, rna-seq
- GSE227974 MY-COMP, an inhibitor of the transcriptional activity of YAP-B-MYB, identifies NEK2 as a novel mediator of YAP oncogenesis in uveal melanoma cells 29 samples shares transcription, inhibitor
- GSE314310 Cardiopedia-Ligand: a Ligand Stimulation Atlas for Cardiac Function and Transcriptional Response 468 samples shares transcription
- GSE271676 Spatial Transcriptional Landscape of Human Heart Failure 178 samples shares transcription
- GSE274546 The Multi-Layered Transcriptional Architecture of Glioblastoma Ecosystems [10X] 121 samples shares transcription
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.